Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices

ASAIO Journal

Volumn 55, Issue 5, 2009, Pages 459-464

  Radovancevic, Rajko ^a   Matijevic, Nena ^b   Bracey, Arthur W ^a   Radovancevic, Branislav ^a   Elayda, MacArthur ^a   Gregoric, Igor D ^a   Frazier, O H ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PLATELETS; BLOOD SAMPLES; CIRCULATORY SUPPORT; GLYCOPROTEIN (GP); HEART FAILURE; LEFT VENTRICULAR ASSIST DEVICES; MONOCYTE ACTIVATION; NEGATIVE CORRELATION; P-SELECTIN GLYCOPROTEIN LIGAND-1; PLATELET ACTIVATION; POSITIVE CORRELATIONS; SURFACE GLYCOPROTEINS; THROMBOSPONDIN;

BLOOD SUBSTITUTES; BODY FLUIDS; FLOW CYTOMETRY; GLYCOPROTEINS; MODEL PREDICTIVE CONTROL; PREDICTIVE CONTROL SYSTEMS;

PLATELETS;

CD14 ANTIGEN; CD63 ANTIGEN; GLYCOPROTEIN IIIA; P SELECTIN GLYCOPROTEIN LIGAND 1; THROMBOSPONDIN;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLOOD SAMPLING; CELL ACTIVATION; CELL INTERACTION; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; FLOW CYTOMETRY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HUMAN; LEUKOCYTE; MALE; MONOCYTE; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; CELL COMMUNICATION; FEMALE; FLOW CYTOMETRY; HEART-ASSIST DEVICES; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; STROKE;

EID: 70349126308     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3181b235af     Document Type: Article

References (31)

1. Dewald O, Schmitz C, Diem H, et al.: Platelet activation markers in patients with heart assist device. Artif Organs 29: 292-299, 2005.
2. Bonaros N, Mueller MR, Salat A, et al.: Extensive coagulation monitoring in patients after implantation of the MicroMed De- Bakey continuous flow axial pump. ASAIO J 50: 424-431, 2004.
3. Houel R, Mazoyer E, Boval B, et al.: Platelet activation and aggregation profile in prolonged external ventricular support. J Thorac Cardiovasc Surg 128: 197-202, 2004.
4. Potapov EV, Ignatenko S, Nasseri BA, et al.: Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during longterm VAD support. Ann Thorac Surg 77: 869-874, 2004.
5. Frazier OH: The development of an implantable, portable, electrically powered left ventricular assist device. Semin Thorac Cardiovasc Surg 6: 181-187, 1994.
6. Frazier OH, Delgado RM III, Kar B, et al.: First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: A case report. Tex Heart Inst J 31: 157-159, 2004.
7. Radovancevic B, Frazier OH, Duncan JM: Implantation technique for the HeartMate left ventricular assist device. J Card Surg 7: 203-207, 1992.
8. Westaby S, Frazier OH, Pigott DW, et al.: Implant technique for the Jarvik 2000 heart. Ann Thorac Surg 73: 1337-1340, 2002.
9. Macey M, McCarthy D, Azam U, et al.: EDTA-CTAD: A novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood. Cytometry B Clin Cytom 52B: 30-40, 2003.
10. Warrino DE, DeGennaro LJ, Hanson M, et al.: Stabilization of white blood cells and immunologic markers for extended analysis using flow cytometry. J Immunol Methods 305: 107-119, 2005.
11. Michelson AD, Barnard MR, Krueger LA, et al.: Evaluation of platelet function by flow cytometry. Methods 21: 259-270, 2000.
12. Schmitz G, Rothe G, Ruf A, et al.; for the European Working Group on Clinical Cell Analysis: European working group on clinical cell analysis: Consensus protocol for flow cytometric characterization of platelet function. Thromb Haemost 79: 885-896, 1998.
13. Wilhelm CR, Ristich J, Kormos RL, et al.: Monocyte tissue factor expression and ongoing complement generation in ventricular assist device patients. Ann Thorac Surg 65: 1071-1076, 1998.
14. Weiss AJ, Bray PF, Tayback MT, et al.: The platelet glycoprotein IIIa polymorphism PlA2 and inherited platelet risk factor for coronary thrombotic events. N Engl J Med 334: 1090-1094, 1996.
15. Aleksic N, Juneja H, Folsom AR, et al.: Platelet PlA2 allele and incidence of coronary heart disease: Results from the Atherosclerosis Risk In Communities (ARIC) study. Circulation 102: 1901-1905, 2000.
16. Michelson AD, Barnard MR, Krueger LA, et al.: Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary interventions, and human acute myocardial infarction. Circulation 104: 1533-1537, 2001.
17. Fontes ML, Mathew JP, Rinder HM, et al.: Multicenter study of perioperative ischemia (McSPI) research group. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 101: 17-23, 2005.
18. Rinder CS, Bonan JL, Rinder HM, et al.: Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 79: 1201-1205, 1992.
19. Zalai CV, Kolodziejczyk MD, Pilarski L, et al.: Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 38: 1340-1347, 2001.
20. Lee WH, Lee Y, Jeong JO, et al.: Activation of CD14 on circulating monocytes in patients with acute coronary syndrome. Int J Cardiol 80: 135-142, 2001.
21. McEver RP, Cummings RD: Perspectives series: Cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100: 485-491, 1997.
22. Lorant DE, McEver RP, McIntyre TM, et al.: Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. J Clin Invest 96: 171-182, 1995.
23. Shibamiya A, Tabuchi N, Chung J, et al.: Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass. Thromb Haemost 92: 124-131, 2004.
24. Osterud B: The role of platelets in decrypting monocyte tissue factor. Semin Hematol 38: 2-5, 2001.
25. Bokarewa MI, Morrissey JH, Tarkowski A: Tissue factor as a proinflammatory agent. Arthritis Res 4: 190-195, 2002.
26. Garlichs CD, Kozina S, Fateh-Moghadam S, et al.: Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 34: 1412-1418, 2003.
27. (Erratum in: Stroke 34: 1820, 2003).
28. Snyder TA, Eash HJ, Litwak KN, et al.: Blood biocompatibility assessment of an intravenous gas exchange device. Artif Organs 30: 657-664, 2006.
29. Loebe M, Koster A, Sanger S, et al.: Inflammatory response after implantation of a left ventricular assist device: Comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. ASAIO J 47: 272-274, 2001.
30. Gawaz M, Neumann FJ, Ott I, et al.: Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis. Coron Artery Dis 8: 121-128, 1997.
31. Gawaz M, Fateh-Moghadam S, Pilz G, et al.: Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 25: 843-851, 1995.